In this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Jacques Raphael, MD, MSc, FRCPC
Advertisement
Articles by Jacques Raphael, MD, MSc, FRCPC
Advertisement
Latest Updated Articles
Bone-Targeted Therapy in Early Breast CancerPublished: November 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
3
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
4
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
5
